Three Badger alumni and a Wisconsin pharmacy leader are honored for their contributions to the field.
Pharmaceutical Sciences Division
5 New Assistant Professors Advance School’s Research and Teaching
Three new hires and two new appointments strengthen the School’s Pharmacy Practice and Pharmaceutical Sciences Divisions.
New Award Will Support Faster, More Powerful Drug Lead Development
The School’s Professor Weiping Tang is the principal investigator on the project that won funding from the UW2020: WARF Discovery Initiative program.
Taking Cues From Nature to Unlock Pharmaceutical Potential
Assistant Professor Jason Kwan, in the Pharmaceutical Sciences Division, is researching microbialites in South Africa to unearth new pharmaceutical tools.
Pharmaceutical Sciences Program Unlocks Career Potential for Graduate Students
To give PhD students in the Pharmaceutical Sciences Division a sense of what’s possible, the School invited alumni from academia, industry, and non-traditional careers to share their stories.
Searching the Sea, and Bacterial Battles, for New Antibiotics
The School’s Tim Bugni and Lingjun Li are using coculturing techniques to recreate aspects of real ecosystems to spur dormant and hidden antibiotic capacities into action.
Pharmaceutical Industry Executive Shines Light on the Career Possibilities of a PhD to Do Good
Alumnus Azita Saleki-Gerhardt, president of operations at one of the world’s 10 largest pharmaceutical companies, returned to the School to share her broad experiences in the pharmaceutical industry.
Far From the Shire, a Hobbit Gets Its Name
Research Associate Sarah Neuman’s investigation into the hobbit mutation unlocks potential new ways to find human diabetes treatments.
Sweetening the Process of Biomarker Discovery in Alzheimer’s Disease
Professor Lingjun Li is working to develop powerful tools to discover Alzheimer’s disease biomarkers to drive early detection, diagnosis, and treatment.
Improving Cancer Diagnosis and Treatment
Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.